Company Filing History:
Years Active: 2013
Title: Kayo Tanigawa: Innovator in Adhesive Skin Patch Technology
Introduction
Kayo Tanigawa is a prominent inventor based in Hirakata, Japan. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative adhesive skin patches. Her work focuses on enhancing the therapeutic effects of medications through advanced delivery systems.
Latest Patents
Kayo Tanigawa holds a patent for a water-based adhesive skin patch containing butenafine hydrochloride. This invention is designed to provide excellent storage stability and effective accumulation of the active ingredient on the skin or nails. The patch is characterized by its formulation, which includes butenafine hydrochloride, glycol salicylate, and propylene glycol in a water-containing gel ointment. The specific mixing ratio of glycol salicylate to propylene glycol ranges from 1:2 to 1:30, ensuring optimal performance and therapeutic effect.
Career Highlights
Throughout her career, Kayo Tanigawa has been associated with Teikoku Seiyaku Co., Ltd., a company known for its commitment to pharmaceutical innovation. Her work has not only advanced the field of adhesive patches but has also contributed to improved patient outcomes through effective drug delivery systems.
Collaborations
Kayo has collaborated with notable colleagues, including Takashi Kamakura and Takefumi Hoshikawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.
Conclusion
Kayo Tanigawa's contributions to adhesive skin patch technology exemplify her dedication to improving therapeutic methods. Her innovative approach continues to influence the field and enhance patient care through effective medication delivery systems.